Compare Global X NASDAQ 100 Covered Call ETF (QYLD) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X NASDAQ 100 Covered Call ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Global X NASDAQ 100 Covered Call ETF trades at $18.68 (market cap $8.49B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.51 (market cap $2.27B). The key difference: Global X NASDAQ 100 Covered Call ETF is far larger — about 3.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| QYLD | SLS | |
|---|---|---|
Market Cap | $8.49B | $2.27B |
Volume | 2,913,938 | 4,179,659 |
Sector | Income / Options Overlay | Health |
52-Week High | $18.68 | $15.46 |
52-Week Low | $16.70 | $1.39 |
Typical Hold Time | 50 Days | — |
Enterprise Value | — | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QYLD trades at $18.68 with no recent price movement, maintaining a stable position amidst mixed technical signals. The ETF shows a bullish moving average trend but bearish oscillators, with RSI indicating potential overbought conditions. Recent dividend distributions of $0.18 per share demonstrate consistent income generation, though news coverage highlights concerns about long-term capital erosion and tax implications of the covered call strategy.
The outlook for QYLD remains income-focused with limited growth potential. While the 12% yield provides attractive monthly cash flow, the strategy caps upside participation in Nasdaq rallies. Key risks include declining option premiums, distribution sustainability concerns, and ordinary income tax treatment that may surprise investors expecting return-of-capital benefits.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
